Ashland Q4 adjusted profit misses estimates; forecasts higher 2027 sales

By Reuters News


Overview

  • U.S. specialty ingredients maker's fiscal Q4 revenue rose 4% but slightly missed analyst expectations

  • Adjusted EPS for Q4 missed analyst expectations despite rising to $1.12 from $1.08 a year earlier

  • Company posted a net loss of $16 mln, versus net income a year earlier


Outlook

  • Ashland sees fiscal 2027 sales of $1.905-$1.975 bln

  • Company expects fiscal 2027 adjusted EBITDA of $405-$435 mln

  • Ashland expects resilient demand in Life Sciences and Personal Care for fiscal 2027


Result Drivers

  • HIGHER SALES VOLUMES - Co said Q4 sales volumes increased, driven by Life Sciences and Personal Care growth

  • PRICE INCREASES - Co said pricing actions offset higher raw material costs in Q4

  • SPECIALTY ADDITIVES PRESSURE - Co said lower Hopewell productivity and unfavorable absorption reduced Specialty Additives earnings


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

Slight Miss*

$498 mln

$501.81 mln (8 Analysts)

Q4 Loss Per Share

$0.35

Q4 Net Loss

$16 mln

Q4 Adjusted EPS

Miss

$1.12

$1.28 (10 Analysts)

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the diversified chemicals peer group is "buy"

  • Wall Street's median 12-month price target for Ashland Inc. is $80.00, about 9.6% above its November 3 closing price of $73.02

  • The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 17 three months ago


Reuters Recommended Reads

  • Nov 3 - DuPont raises annual profit forecasts, sees upbeat Q4 on healthcare, aerospace strength

  • Nov 2 - Celanese Q3 sales rise 6%

  • Nov 3 - Flavors and fragrances maker IFF's Q3 sales beat; low end of 2026 outlook raised


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk